Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

Only one known person in the world can save my life

google.com·16w

Stem cell donation: 'Only one known person in the world can save my life'

google.com·16w

Evaluating Infection Patterns Among Patients With Multiple Myeloma Receiving BCMA ...

google.com·16w

Novartis perseveres with pelabresib | ApexOnco

google.com·16w

Can Karyopharm Unlock Xpovio's Growth In 2026 With Pivotal Myelofibrosis Data Ahead?

google.com·16w

Taiwan's PharmaEssentia gains US recognition for rare blood disorder drug

google.com·16w

CARDIAC DISEASE AND HYPERTENSION IN POLYCYTHEMIA VERA

google.com·16w

Helping You Understand Stage 2 Essential Thrombocythemia

google.com·16w

Opna Bio's OPN-2853 secures FDA's orphan drug status for myelofibrosis

google.com·16w

Reevaluating Myeloproliferative Neoplasms : Iron and JAK2 Insights

google.com·16w

Study Explores Role of JAK2 Allelic Burden and Iron Parameters in Diagnosing ...

google.com·16w

Updated NCCN Guidelines Strengthen Support for Breast Cancer Index® in Extended ...

google.com·16w

WJ01024 Is Safe, Drives Durable Spleen Responses in R/R Myelofibrosis

google.com·16w

Zavabresib Granted Orphan Drug Designation for Myelofibrosis

google.com·16w

Patient Develops Acute Psychosis Linked to Ruxolitinib Treatment for Myelofibrosis

google.com·16w

Ruxolitinib Sparks Acute Psychosis in Myelofibrosis Patient

google.com·16w

Personalized Therapies and Expanded Role of Pharmacists Enhance Myelofibrosis ...

google.com·17w

Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026

google.com·17w

Zavabresib Earns FDA Orphan Drug Designation in Myelofibrosis

google.com·17w

FDA Orphan Drug Designation Granted to Zavabresib for Myelofibrosis

google.com·17w

Log in to enable infinite scrolling